Arkolith/Insider Trading/MDGL/Form 4

Taub Rebecca

DirectorMADRIGAL PHARMACEUTICALS, INC. (MDGL) · full profile →Form 4 · filed Jan 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$9.6M
Net Open-Market Flow
-$9.6M
Transactions
30
29 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 9, 2026Sell(S)465$528.16$246K458K
Jan 9, 2026Sell(S)554$529.28$293K458K
Jan 9, 2026Sell(S)256$530.45$136K458K
Jan 9, 2026Sell(S)30$531.05$16K458K
Jan 9, 2026Sell(S)40$532.50$21K458K
Jan 9, 2026Sell(S)271$534.18$145K457K
Jan 9, 2026Sell(S)89$534.93$48K457K
Jan 9, 2026Sell(S)299$535.80$160K457K
Jan 9, 2026Sell(S)385$536.88$207K456K
Jan 9, 2026Sell(S)40$537.84$22K456K
Jan 9, 2026Sell(S)400$539.26$216K456K
Jan 9, 2026Sell(S)40$540.26$22K456K
Jan 9, 2026Sell(S)400$542.72$217K456K
Jan 9, 2026Option exercise(M)18K$15.80$291K474K
Jan 9, 2026Sell(S)960$512.02$492K473K
Jan 9, 2026Sell(S)960$513.12$493K472K
Jan 9, 2026Sell(S)937$514.63$482K471K
Jan 9, 2026Sell(S)2K$515.82$814K470K
Jan 9, 2026Sell(S)521$516.81$269K469K
Jan 9, 2026Sell(S)2K$517.84$1.1M467K
Jan 9, 2026Sell(S)970$518.67$503K466K
Jan 9, 2026Sell(S)539$519.89$280K465K
Jan 9, 2026Sell(S)440$521.11$229K465K
Jan 9, 2026Sell(S)588$521.95$307K464K
Jan 9, 2026Sell(S)732$522.98$383K464K
Jan 9, 2026Sell(S)1K$524.06$700K462K
Jan 9, 2026Sell(S)1K$525.12$782K461K
Jan 9, 2026Sell(S)913$526.05$480K460K
Jan 9, 2026Sell(S)1K$526.95$598K459K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 9, 2026Option exercise(M)18K—$0240

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-001961) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML